Literature DB >> 1949928

Patterns of nicotine gum use in a health maintenance organization.

R E Johnson1, J F Hollis, V J Stevens, G T Woodson.   

Abstract

Nicotine chewing gum is designed as an aid to smokers who intend to stop smoking. However, the efficacy of the gum in general medical practice has been questioned. This study describes the extent of nicotine chewing gum use among health maintenance organization members, the characteristics of prescribers and users, and the patterns of gum use over a two-year period. About 0.4 percent of Kaiser Permanente, Northwest Region members were exposed to the gum. Over the two-year observation period, 1970 members received at least one box (96 pieces) of the gum. Almost 70 percent of users received only one box of the gum. About 1.5 percent of users appeared to use the gum continuously at a daily dosage around the level needed to replace the nicotine addiction among most smokers, and for longer than the recommended three months. Another 2.5 percent appeared to use the gum continuously but at less than a nicotine-addiction replacement dose for longer than the recommended maximum of six months. The presence of a prepaid prescription drug benefit directly affected whether or not a person received the gum and how long he used it. The extreme variation in the patterns of use raises the questions of why the gum is used in this manner, and how effective it is when used in this manner.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1949928     DOI: 10.1177/106002809102500705

Source DB:  PubMed          Journal:  DICP        ISSN: 1042-9611


  7 in total

Review 1.  A meta-analysis of the efficacy of over-the-counter nicotine replacement.

Authors:  J R Hughes; S Shiffman; P Callas; J Zhang
Journal:  Tob Control       Date:  2003-03       Impact factor: 7.552

2.  Persistent use of nicotine replacement therapy: an analysis of actual purchase patterns in a population based sample.

Authors:  S Shiffman; J R Hughes; J L Pillitteri; S L Burton
Journal:  Tob Control       Date:  2003-09       Impact factor: 7.552

3.  Community patterns of transdermal nicotine use and provider counseling.

Authors:  S H Swartz; A J Ellsworth; S J Curry; E J Boyko
Journal:  J Gen Intern Med       Date:  1995-12       Impact factor: 5.128

4.  Drug prices and third party payment: do they influence medication selection?

Authors:  J E Hux; C D Naylor
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

Review 5.  More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder.

Authors:  M J Moerke; L R McMahon; J L Wilkerson
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

6.  Addressing tobacco in managed care: results of the 2002 survey.

Authors:  Carol McPhillips-Tangum; Carmella Bocchino; Rita Carreon; Caroline Erceg; Bob Rehm
Journal:  Prev Chronic Dis       Date:  2004-09-15       Impact factor: 2.830

7.  A randomized controlled trial of two different lengths of nicotine replacement therapy for smoking cessation.

Authors:  Abu S Abdullah; Anthony J Hedley; Sophia S C Chan; Tai-Hing Lam
Journal:  Biomed Res Int       Date:  2013-09-09       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.